Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma

Published:2021-05 Issue:5 Volume:57 Page:323-329
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:en
Short-container-title:Archivos de Bronconeumología

Author:

Taus Álvaro,Camacho Laura,Rocha Pedro,Hernández Ainhoa,Longarón Raquel,Clavé Sergi,Fernández-Ibarrondo Lierni,Salido Marta,Hardy-Werbin Max,Fernández-Rodríguez Concepción,Albanell Joan,Bellosillo Beatriz,Arriola Edurne

Funder

Generalitat de Catalunya

Fundación Cellex

Xarxa de Bancs de Tumors de Catalunya

Agència de Gestió d'Ajuts Universitaris i de Recerca

Instituto de Salud Carlos III

Fundació la Marató de TV3

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2019

2. Prognostic and predictive value in KRAS in non-small-cell lung cancer;Wood;JAMA Oncol,2016

3. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung;Slebos;N Engl J Med,1990

4. Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy;Shepherd;J Clin Oncol,2013

5. KRAS mutations in advanced nonsquamous non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive value;Mellema;J Thorac Oncol,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues;Cancer Discovery;2024-03-19

2. Biomarkers of respiratory diseases;Biological Insights of Multi-Omics Technologies in Human Diseases;2024

3. [Translated article] Biological Biomarkers in Respiratory Diseases;Archivos de Bronconeumología;2022-04

4. Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges;Science Advances;2022-01-28